Helmholtz Innovation Platform for Accelerator-based Technologies and Solutions.

Beyond the circle of its founders, Hi-Acts also aims to connect other research centres more closely with each other and with company and hospital researchers.

Together, they can utilise existing particle accelerators more effectively and develop new facilities that are even better adapted to the needs of industry. These could include compact, and hence decentralised, accelerators which can be used to develop medicines much more quickly and cost-effectively, to carry out high-precision quality tests at companies themselves and to perform proton therapy to fight cancer in hospitals.

Hi-Acts seeks to take on as a group projects which individual companies cannot tackle on their own or that are too risky for private investment.

Hi-Acts provides an uncomplicated meeting place for supply and demand, science and industry. Players from a wide range of high-tech fields – including medical research, materials research, structural research, energy technology and laser technology – are given access to a versatile infrastructure including large-scale research facilities, expert advice and funding opportunities, via a central point of contact. At Hi-Acts Connect, a contact checks and provides individual and free advice as to whether and how Hi-Acts and all the parties involved can offer help: Who is the right partner for the project? What support can the network offer? Is funding potentially available? If necessary, a test run can be carried out with the appropriate accelerator technology.

Hi-Acts sees itself as a marketplace for successful transfer. Research, industry and medicine work together to achieve scientific and technological breakthroughs and use these to efficiently and quickly develop specific processes or products that can move society forward. Deep tech for a more sustainable, healthier and fairer world.